Inergetics (NRTI) 10-Q 14 Aug 14 2014 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 06, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'INERGETICS INC	'
Entity Central Index Key	'0000072170	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'NRTI	'
Entity Common Stock, Shares Outstanding	'	89,353,268

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash	$15,313	$106,773
Accounts receivable, net	583,297	472,297
Receivable from the Technology Business Tax Certificate Transfer Program	0	3,357,144
Deferred cost of goods sold	493,539	569,036
Inventories, net	972,526	420,186
Prepaid expenses	462,849	447,355
Total Current Assets	2,527,524	5,372,791
Patents and intangible assets, net	148,603	149,391
Goodwill	135,000	135,000
Deposits	201,099	421,191
Total Assets	3,012,226	6,078,373
Current Liabilities:	'	'
Accounts payable and accrued expenses	3,551,849	5,089,488
Deferred Revenue	1,075,182	1,269,470
Obligations to be settled in stock	849,433	699,085
Derivative liability	790,000	318,000
Short-term debt, net of unamortized debt discount	2,403,645	1,276,358
Short-term debt to affiliates, net of unamortized debt discount	3,756,709	2,843,728
Total Current Liabilities	12,426,818	11,496,129
Long-term debt	259,479	103,912
Long-term debt, net to affiliates	0	1,425,522
Total liabilities	12,686,297	13,025,563
Commitments and Contingencies	'	'
Preferred stock, Convertible Series G, authorized 400,000 par $1, stated Value $50: 215,281 and 198,074 shares issued and outstanding	9,092,217	8,743,284
Preferred stock:	'	'
Common stock, par value $0.001; authorized 2,000,000,000 shares; issued and outstanding 82,295,000 and 62,461,448 shares, respectively	82,295	62,462
Additional paid-in capital	71,463,122	68,789,021
Accumulated Deficit	-90,506,750	-84,737,002
Total Stockholders’ Deficit	-18,766,288	-15,690,474
Total Liabilities and Stockholders’ Deficit	3,012,226	6,078,373
Convertible Series B	'	'
Preferred stock:	'	'
Preferred stock	130,282	130,282
Cumulative Series C	'	'
Preferred stock:	'	'
Preferred stock	64,763	64,763
Convertible Series D	'	'
Preferred stock:	'	'
Preferred stock	0	0
Convertible Series E	'	'
Preferred stock:	'	'
Preferred stock	0	0
Convertible Series F	'	'
Preferred stock:	'	'
Preferred stock	$0	$0

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Preferred stock, Convertible Series G, authorized	400,000	400,000
Preferred stock, Convertible Series G, par value	$1	$1
Preferred stock, Convertible Series G, stated value	$50	$50
Preferred stock, Convertible Series G, shares issued	215,281	198,074
Preferred stock, Convertible Series G, shares outstanding	215,281	198,074
Common stock, par value	$0.00	$0.00
Common stock, authorized	2,000,000,000	2,000,000,000
Common stock, issued	82,295,000	62,461,448
Common stock, outstanding	82,295,000	62,461,448
Convertible Series B	'	'
Preferred stock, par value	$2	$2
Preferred Stock, shares issued	65,141	65,141
Preferred stock, shares outstanding	65,141	65,141
Cumulative Series C	'	'
Preferred stock, par value	$1	$1
Preferred Stock, shares issued	64,763	64,763
Preferred stock, shares outstanding	64,763	64,763
Convertible Series D	'	'
Preferred stock, par value	$1	$1
Preferred Stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Convertible Series E	'	'
Preferred stock, par value	$1	$1
Preferred Stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Convertible Series F	'	'
Preferred stock, par value	$1	$1
Preferred Stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Total Revenues	$523,615	$66,667	$1,003,417	$73,442
Cost of Goods Sold	310,437	50,475	673,040	55,245
Gross Profit	213,178	16,192	330,377	18,197
Research and development	8,521	0	12,929	0
Selling, general and administrative expense	1,555,511	866,787	4,696,231	2,258,683
Total operating expenses	1,564,032	866,787	4,709,160	2,258,683
Loss from Operations	-1,350,854	-850,595	-4,378,783	-2,240,486
Other Income (Expense)	'	'	'	'
Amortization of debt discount	-35,650	-45,078	-169,003	-82,132
Gain on extinguishment of debt	2,787	46,978	18,378	46,978
Gain (loss) on fair market valuation of derivatives	542,000	35,000	-472,000	-36,000
Interest and financing cost, net	-400,970	-118,502	-768,340	-199,309
Total Other Income (Expense)	108,167	-81,602	-1,390,965	-270,463
Loss before Provision for Income taxes	-1,242,687	-932,197	-5,769,748	-2,510,949
State taxes	0	-500	0	-3,999
Net Loss	-1,242,687	-932,697	-5,769,748	-2,514,948
Preferred Dividend	-321,525	-302,000	-579,963	-743,900
Net Loss applicable to common shareholders	($1,564,212)	($1,234,697)	($6,349,711)	($3,258,848)
Net Loss per Common Share - Basic and Diluted	($0.02)	($0.02)	($0.09)	($0.06)
Weighted Average Number of common shares outstanding - Basic and Diluted	78,183,619	53,022,927	71,135,031	50,657,324

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities	'	'
Net Loss	($5,769,748)	($2,514,948)
Adjustments to Reconcile Net Loss to Net Cash Used In Operations	'	'
Loss on fair market valuation of derivatives	472,000	36,000
Depreciation and amortization	788	763
Common Stock issued for financing expenses	17,365	0
Preferred Stock issued for financing expenses	262,418	0
Common Stock issued for services	199,609	59,500
Common stock issued for compensation	1,332,883	450,600
Amortization of Prepaid expenses paid for in stock	0	0
Gain on extinguishment of debt	-18,378	-46,978
Accretion of debt discount	169,003	82,132
Changes in Assets and Liabilities	'	'
(Increase) in accounts receivable	-111,000	-55,971
Decrease in receivable from Technology Business Tax Certificate Transfer Program	3,357,144	2,209,715
(Increase) in inventories	-552,340	-138,297
Decrease in deferred cost of goods sold	75,497	0
(Increase) Decrease in prepaid expenses	-215,103	22,073
(Increase) in note receivable	0	-5,128
(Increase) of intangible assets	0	-41,000
(Increase) Decrease in deposits	220,092	-4,666
(Decrease) in accounts payable and accrued expenses	-304,434	22,572
(Decrease) in customer deposits	0	-39,970
(Decrease) in deferred Revenue	-194,288	0
Net Cash (Used in) Provided by Operating Activities	-1,058,490	36,397
Cash Flows from Investing Activities	'	'
Acquisition of business	0	-75,000
Net Cash Provide by Investing Activities	0	-75,000
Cash Flows from Financing Activities	'	'
Proceeds from debt	1.49503	1,203,090
Repayment of debt	-528,000	0
Net Cash Used in Financing Activities	967.03	31,568
Net Decrease in Cash	-91,460	-7,035
Cash at beginning of period	106,773	8,846
Cash at end of period	15,313	1,811
Supplemental Disclosure of Cash Flow information:	'	'
Interest Expense	213,621	85,575
Income Taxes	0	3,999
Non-cash	'	'
Issuance of G shares as Preferred dividend (9,851 and 14,878 shares)	579,963	743,900
Common Stock	'	'
Non-cash	'	'
Stock issued for services	399,163	0
Prepaid Expense	'	'
Non-cash	'	'
Stock issued for services	150,348	333,863
Business Acquisition	'	'
Non-cash	'	'
Stock issued for services	$0	$140,000

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Stock issued for services, shares	1,850,000	'
Issuance of redeemable preferred stock shares	9,851	14,878

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the Company or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., is a holding company for its subsidiary Millennium Biotechnologies, Inc. ("Millennium").
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey.  Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science.  Millennium’s principal source of revenue is from sales of its nutraceutical supplements, Resurgex Select® and Resurgex Essential™ and Resurgex Essential Plus™ which serve as a nutritional support for immuno-compromised individuals undergoing medical treatment for chronic debilitating diseases. Millennium has developed Surgex for the sport nutritional market. The Company acquired Bikini Ready®, a leader in weight loss lifestyle solutions and SlimTrim™, the affordable, premium value diet brand. The Company has a licensing agreement to sell the Martha Stewart Essentials line of supplements.   The Company’s efforts going forward will focus on sales of Martha Stewart Essentials™ line of supplements, Surgex in powder and pill forms as well as powder and pills for Bikini Ready and pills for SlimTrim.
	The accompanying unaudited condensed consolidated financial statements include the accounts of Inergetics, Inc. and its subsidiary. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Certain information in footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States of America has been condensed or omitted pursuant to such principles and the financial results for the periods presented may not be indicative of the full year’s results. The Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the December 31, 2013 audited financial statements and the accompanying notes thereto filed with the Securities and Exchange Commission on Form 10-K.
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its subsidiary and are prepared in accordance with accounting principles generally accepted in the United States.  All significant inter-company transactions and balances have been eliminated.
	Certain information in footnote disclosure normally included in the financial statements have been condensed or omitted and the financial statements might not be indicative of a full year’s results. The Company believes the disclosures are adequate to make the information presented not misleading.
	The financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the fiscal year-ended December 31, 2013 included in the Company’s Annual Report on Form 10-K filed on March 31, 2014.
	Use of Estimates
	The preparation of the financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Goodwill
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment.
	Revenue Recognition
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which occurs at shipping (F.O.B. terms).   Upon shipment to various customers when all performance obligations are met and collectability is reasonably assured revenue is recognized.   Upon shipment to specific customers with the right of return the Company defers revenues as returns are not reasonably estimable.   As of June 30, 2014 and December 31, 2013, deferred revenue totaled $1,075,182 and $1,269,470, respectively.
	Deferred Revenue and Deferred Cost of Goods Sold
	Deferred revenue consists substantially of amounts billed or payments received in advance of revenue recognition. Deferred cost of goods sold as of June 30, 2014 and December 31, 2013 of $493,539 and $569,036, respectively, related to deferred product revenues includes direct product costs. Once all revenue recognition criteria have been met, the deferred revenues and associated cost of goods sold are recognized.
	Income Taxes
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
	Loss Per Common Share
	Net loss per share, in accordance with the provisions of ASC 260, “Earnings Per Share” is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. Common Stock equivalents have not been included in this computation since the effect would be anti-dilutive. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock and convertible debt are not considered in the diluted income (loss) per share calculation since the effect would be anti-dilutive.
	Fair Value of Financial Instruments
	For financial instruments including cash, accounts receivable, prepaid expenses, debt, accounts payable and accrued expenses, the carrying values approximated their fair value.
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

GOING_CONCERN_AND_LIQUIDITY_IS

GOING CONCERN AND LIQUIDITY ISSUES	6 Months Ended
	Jun. 30, 2014
Going Concern And Liquidity Issues [Abstract]	'
GOING CONCERN AND LIQUIDITY ISSUES	'
	2 . GOING CONCERN AND LIQUIDITY ISSUES
	The Company’s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing.  Management believes they can raise the appropriate funds needed to support their business plan and develop an operating company which is cash flow positive.
	However, the Company has a working capital deficit, significant debt outstanding, incurred substantial net losses for the six months ended June 30, 2014 and 2013 and has accumulated a deficit of approximately $91 million at June 30, 2014. The Company has not been able to generate sufficient cash from operating activities to fund its ongoing operations. There is no guarantee that the Company will be able to generate enough revenue and/or raise capital to support its operations.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The condensed consolidated financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern.

CONCENTRATIONS_OF_BUSINESS_AND

CONCENTRATIONS OF BUSINESS AND CREDIT RISK	6 Months Ended
	Jun. 30, 2014
Risks and Uncertainties [Abstract]	'
CONCENTRATIONS OF BUSINESS AND CREDIT RISK	'
	3	CONCENTRATIONS OF BUSINESS AND CREDIT RISK
	The Company maintains cash balances in several financial institutions which are insured by the Federal Deposit Insurance Corporation up to certain federal limitations.
	The Company provides credit in the normal course of business to customers located throughout the U. S. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2014
Disclosure - Inventories [Abstract]	'
INVENTORIES	'
	4	INVENTORIES
	Inventories are stated at the lower of cost or market on a first in, first out basis. Inventories consist of work-in-process, raw materials, finished goods, and packaging for the Company’s Martha Stewart Essentials, SURGEX®, RESURGEX ESSENTIAL ®, Bikini Ready® and SlimTrim™ product lines. Inventories consist of the following:
			June 30,		December 31,
			2014		2013
	Finished Goods		$	912,574	$	378,472
	Packaging			59,952		41,714
				972,526		420,186
	Less: Reserve for obsolescence			-		-
	Total		$	972,526	$	420,186

PREPAID_EXPENSES

PREPAID EXPENSES	6 Months Ended
	Jun. 30, 2014
Prepaid Expenses Disclosure [Abstract]	'
PREPAID EXPENSES	'
	5	PREPAID EXPENSES
	Prepaid expenses are for services that have been paid in advance primarily with stock that are amortized over the life of the contract. The agreements pertain to pricing structure, distribution, warehousing, inventory management, financial advisory services, pro athlete endorsements and licensing agreements.

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	6 Months Ended
	Jun. 30, 2014
Payables and Accruals [Abstract]	'
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	'
	6	ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following:
			June 30,		December 31,
			2014		2013
	Accounts payable		$	2,567,449	$	2,866,017
	Owed to officer			30,650		16,088
	Accrued interest			453,827		1,016,584
	Accrued rent expense			135,874		135,874
	Accrued salaries, bonuses and payroll taxes			113,615		824,492
	Accrued professional fees			250,434		230,433
			$	3,551,849	$	5,089,488

SHORT_TERM_DEBT_NET_OF_DEBT_DI

SHORT TERM DEBT, NET OF DEBT DISCOUNT	6 Months Ended
	Jun. 30, 2014
Short-term Debt, Other Disclosures [Abstract]	'
SHORT TERM DEBT, NET OF DEBT DISCOUNT	'
	7	SHORT TERM DEBT, NET OF DEBT DISCOUNT
	In the first Six months of 2014, the Company realized gross proceeds of $1,495,030 in new cash. Proceeds from the sale of its 12% to 15.0% twelve month Unsecured Convertible Notes and Unsecured Notes, in the aggregate original principal amount of $1,495,030 (the “Notes”) to accredited investors (the “Investors”).  Interest on the outstanding principal balance of the Notes is payable upon maturity of the note. For the convertible notes, the outstanding principal balance of the Notes and all accrued but unpaid interest thereon may be converted at any time at the option of each Investor into shares of Common Stock at the Conversion Price of $ .20 per share.  The Company may prepay the Notes at any time without penalty to the Investors.
	Unsecured Notes, net debt discount, consist of the following:
			June 30,		December 31,
			2014		2013
	Unsecured Convertible Notes		$	2,739,271	$	1,450,333
	Debt discount			-76,147		-70,063
				2,663,124		1,380,270
	Less long term portion			259,479		103,912
	Short term portion		$	2,403,645	$	1,276,358
	The Company committed to issue 561,918 shares of common stock for origination fees during the Six months ended June 30, 2014 and recorded a debt discount of $ 77,207.
	Gain on Troubled Debt Restructuring
	2014 Modification of Debt
	The following debt instruments were modified in 2014. The modification of debt included the addition of a conversion feature therefore requiring the Company to record the transaction in accordance with ASC 470 “Debt” modification of debt accounting.
	At December 31, 2013, the Company had promissory notes issued to one affiliated investor with an outstanding balance of $2,000,000, which were due on demand. During January 2014, the Company reached an agreement with the investor to extend the debt for twelve months. At the date of extension, the new debt payable was $2,000,000. The new debt incurred origination fees paid through the issuance of Series G preferred stock valued at $232,500, resulting in an adjustment to Stockholders’ Deficit.
	At December 31, 2013, the Company had promissory notes issued to three accredited investors with an outstanding balance of $249,535, which were due on demand. During January 2014, the Company reached an agreement with the investors to extend the debt for six to twelve months. At the date of extension, the debt payable was $249,535. The fair value of the new debt is $223,548. The conversion rate on the new convertible note is $0.20 per share of common stock. As of June 30, 2014 the loss on debt modification of $25,987 has been included in the Statement of Operations. The loss incurred with debt restructuring approximates $0.00 per share.
	At December 31, 2013, the Company had Notes issued to six accredited investors with an outstanding principal and interest balance of $465,872, which were due on demand. In the six months ended June 30, 2014, the Company reached an agreement with the investors to convert into 1,336,918 shares of common stock plus $43,725 in cash as full settlement. The debt and accrued interest was valued at $506,801 which exceeded the fair market value of the common stock and cash by $18,378. The difference resulted in a gain on troubled debt restructuring of $18,378 has been included in the Statement of Operations in the six months ended June 30, 2014. The gain incurred with debt restructuring approximates $0.00 per share.

SHORT_TERM_DEBT_RELATED_PARTIE

SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT	'
	8	SHORT TERM DEBT – RELATED PARTIES, NET OF DEBT DISCOUNT
	In the Six months ended June 30, 2014, the Company realized gross proceeds of $ 1,085,030, from the sale of its 12.0 % six month Unsecured Convertible Notes and Secured Promissory Notes, in the aggregate original principal amount of $100,000 (the “Notes”) to an accredited investor (the “Investor”).  Interest on the outstanding principal balance of the Notes is payable upon maturity of the note. The Company may prepay the Notes at any time without penalty to the Investors.
	The Company issued 125,000 shares of common stock for origination fees during the Six months ended June 30, 2014, in connection with this debt and recorded a debt discount of $26,740.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	9	FAIR VALUE MEASUREMENTS
	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis
				Fair Value at
				June 30,	Fair Value Measurement Using
				2014	Level 1	Level 2		Level 3
	Derivative liability – Conversion Feature		$	790,000	-	-	$	790,000
			$	790,000	-	-	$	790,000
				Fair Value at
				December 31,	Fair Value Measurement Using
				2013	Level 1	Level 2		Level 3
	Derivative liability – Conversion Feature		$	318,000	-	-	$	318,000
			$	318,000	-	-	$	318,000
	The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities (Derivative liability – Conversion Feature) for the Six months ended June 30, 2014:
				June 30,
				2014
	Balance at December 31, 2013		$	318,000
	Derivative converted into Equity			-8,000
	Change in fair market value of Conversion Feature			480,000
	Balance at June 30, 2014		$	790,000

WARRANTS

WARRANTS	6 Months Ended
	Jun. 30, 2014
Stock Warrants Disclosure [Abstract]	'
WARRANTS	'
	10	WARRANTS
	Warrant activity for the six months ended June 30, 2014 is as follows:
				Weighted
				Average		Remaining	Aggregate
			Number of	Exercise		Contractual Term In	Intrinsic
			Warrants	Price		Months	Value
	Outstanding at December 31, 2013		19,323,406	$	0.2	63	$	300,000
	Granted		-		-	-		-
	Exercised		-531,262		0.104	-		-
	Expired or cancelled		-		-	-		-
	Outstanding and exercisable at June 30, 2014		18,792,144	$	0.197	Aug-88	$	-

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	11	COMMITMENTS AND CONTINGENCIES
	The Company entered into a license agreement with minimum royalty payments totaling $ 1,800,000, $ 2,100,000, $ 2,700,000, $ 3,200,000 and $ 3,800,000 for each of the years ended 2014, 2015, 2016, 2017 and 2018, respectively. $1,350,000 was paid as of June 30, 2014 and recorded in prepaid expenses.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	12	SUBSEQUENT EVENTS
	During the third quarter, the Company was not able to make the payment that was due July 1, 2014 to Martha Stewart Living Omnimedia pursuant to our license agreement. While we are in discussions to work out terms of payment, we most likely will need to raise additional funds to meet our obligations under the license agreement.
	During the third quarter of 2013 the Company received $1,000,000 net proceeds and issued a 12% secured subordinated convertible promissory note to the Investor in the principal amount of $1,500,000 (the “Note”) and a Common Stock Purchase Warrant (the “Warrant”) to purchase 2,500,000 shares of the Company’s Common Stock (the “Common Stock”). Principal and interest (at the rate of 12% per annum) is due and payable under the Note on July 14, 2015. If the Company files a registration statement with the Securities and Exchange Commission (the SEC”) covering the resale of the shares of Common Stock issuable upon conversion of the Note and exercise of the Warrant on or before 45 days after July 14, 2014, the principal amount of the Note shall be reduced by $200,000, and if the registration statement is declared effective by the SEC within 120 days of July 14, 2014, the principal amount of the Notes shall be further reduced by $300,000. Principal and accrued but unpaid interest is convertible into shares of the Company’s Common Stock at a price (the “Conversion Price”) equal the lesser (i) $0.35 per share, or (ii) 62% of the lowest trading price of the Common Stock as quoted by Bloomberg L.P. for the ten trading days immediately preceding the date of conversion (subject to adjustments as provided in the Note). However, in no event shall the Conversion Price be less than $0.031 per share (the “Floor Price”). The Company filed a registration statement with the Securities and Exchange Commission on August 1, 2014, reducing the principal amount by $200,000 to $1,300,000.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Organization	'
	Organization
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the Company or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., is a holding company for its subsidiary Millennium Biotechnologies, Inc. ("Millennium").
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey.  Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science.  Millennium’s principal source of revenue is from sales of its nutraceutical supplements, Resurgex Select® and Resurgex Essential™ and Resurgex Essential Plus™ which serve as a nutritional support for immuno-compromised individuals undergoing medical treatment for chronic debilitating diseases. Millennium has developed Surgex for the sport nutritional market. The Company acquired Bikini Ready®, a leader in weight loss lifestyle solutions and SlimTrim™, the affordable, premium value diet brand. The Company has a licensing agreement to sell the Martha Stewart Essentials line of supplements.   The Company’s efforts going forward will focus on sales of Martha Stewart Essentials™ line of supplements, Surgex in powder and pill forms as well as powder and pills for Bikini Ready and pills for SlimTrim.
	The accompanying unaudited condensed consolidated financial statements include the accounts of Inergetics, Inc. and its subsidiary. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Certain information in footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States of America has been condensed or omitted pursuant to such principles and the financial results for the periods presented may not be indicative of the full year’s results. The Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the December 31, 2013 audited financial statements and the accompanying notes thereto filed with the Securities and Exchange Commission on Form 10-K.
Principles of Consolidation	'
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its subsidiary and are prepared in accordance with accounting principles generally accepted in the United States.  All significant inter-company transactions and balances have been eliminated.
	Certain information in footnote disclosure normally included in the financial statements have been condensed or omitted and the financial statements might not be indicative of a full year’s results. The Company believes the disclosures are adequate to make the information presented not misleading.
	The financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the fiscal year-ended December 31, 2013 included in the Company’s Annual Report on Form 10-K filed on March 31, 2014.
Use of Estimates	'
	Use of Estimates
	The preparation of the financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Goodwill	'
	Goodwill
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment.
Revenue Recognition	'
	Revenue Recognition
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which occurs at shipping (F.O.B. terms).   Upon shipment to various customers when all performance obligations are met and collectability is reasonably assured revenue is recognized.   Upon shipment to specific customers with the right of return the Company defers revenues as returns are not reasonably estimable.   As of June 30, 2014 and December 31, 2013, deferred revenue totaled $1,075,182 and $1,269,470, respectively.
	Deferred Revenue and Deferred Cost of Goods Sold
	Deferred revenue consists substantially of amounts billed or payments received in advance of revenue recognition. Deferred cost of goods sold as of June 30, 2014 and December 31, 2013 of $493,539 and $569,036, respectively, related to deferred product revenues includes direct product costs. Once all revenue recognition criteria have been met, the deferred revenues and associated cost of goods sold are recognized.
Income Taxes	'
	Income Taxes
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.
Loss Per Common Share	'
	Loss Per Common Share
	Net loss per share, in accordance with the provisions of ASC 260, “Earnings Per Share” is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. Common Stock equivalents have not been included in this computation since the effect would be anti-dilutive. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock and convertible debt are not considered in the diluted income (loss) per share calculation since the effect would be anti-dilutive.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	For financial instruments including cash, accounts receivable, prepaid expenses, debt, accounts payable and accrued expenses, the carrying values approximated their fair value.
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

INVENTORIES_Tables

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure - Inventories [Abstract]	'
Inventory	'
	Inventories consist of the following:
		June 30,		December 31,
		2014		2013
	Finished Goods	$	912,574	$	378,472
	Packaging		59,952		41,714
			972,526		420,186
	Less: Reserve for obsolescence		-		-
	Total	$	972,526	$	420,186

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	6 Months Ended
	Jun. 30, 2014
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities	'
	Accounts payable and accrued expenses consisted of the following:
		June 30,		December 31,
		2014		2013
	Accounts payable	$	2,567,449	$	2,866,017
	Owed to officer		30,650		16,088
	Accrued interest		453,827		1,016,584
	Accrued rent expense		135,874		135,874
	Accrued salaries, bonuses and payroll taxes		113,615		824,492
	Accrued professional fees		250,434		230,433
		$	3,551,849	$	5,089,488

SHORT_TERM_DEBT_NET_OF_DEBT_DI1

SHORT TERM DEBT, NET OF DEBT DISCOUNT (Tables)	6 Months Ended
	Jun. 30, 2014
Short-term Debt [Abstract]	'
Unsecured Notes, net debt discount	'
	Unsecured Notes, net debt discount, consist of the following:
		June 30,		December 31,
		2014		2013
	Unsecured Convertible Notes	$	2,739,271	$	1,450,333
	Debt discount		-76,147		-70,063
			2,663,124		1,380,270
	Less long term portion		259,479		103,912
	Short term portion	$	2,403,645	$	1,276,358

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	'
	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis
			Fair Value at
			June 30,	Fair Value Measurement Using
			2014	Level 1	Level 2		Level 3
	Derivative liability – Conversion Feature	$	790,000	-	-	$	790,000
		$	790,000	-	-	$	790,000
			Fair Value at
			December 31,	Fair Value Measurement Using
			2013	Level 1	Level 2		Level 3
	Derivative liability – Conversion Feature	$	318,000	-	-	$	318,000
		$	318,000	-	-	$	318,000
Liabilities measured at fair value on a recurring basis using significant unobservable inputs	'
	The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities (Derivative liability – Conversion Feature) for the Six months ended June 30, 2014:
			June 30,
			2014
	Balance at December 31, 2013	$	318,000
	Derivative converted into Equity		-8,000
	Change in fair market value of Conversion Feature		480,000
	Balance at June 30, 2014	$	790,000

WARRANTS_Tables

WARRANTS (Tables)	6 Months Ended
	Jun. 30, 2014
Stock Warrants Disclosure [Abstract]	'
Warrant Activity	'
	Warrant activity for the six months ended June 30, 2014 is as follows:
			Weighted
			Average		Remaining	Aggregate
		Number of	Exercise		Contractual Term In	Intrinsic
		Warrants	Price		Months	Value
	Outstanding at December 31, 2013	19,323,406	$	0.2	63	$	300,000
	Granted	-		-	-		-
	Exercised	-531,262		0.104	-		-
	Expired or cancelled	-		-	-		-
	Outstanding and exercisable at June 30, 2014	18,792,144	$	0.197	Aug-88	$	-

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]	'	'
Deferred Revenue	$1,075,182	$1,269,470
Deferred Cost Of Goods Sold	$493,539	$569,036

GOING_CONCERN_AND_LIQUIDITY_IS1

GOING CONCERN AND LIQUIDITY ISSUES - Additional Information (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Going Concern [Line Items]	'	'
Accumulated Deficit	($90,506,750)	($84,737,002)

Inventories_Detail

Inventories (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Inventory Disclosure [Line Items]	'	'
Finished Goods	$912,574	$378,472
Packaging	59,952	41,714
Inventory, gross, total	972,526	420,186
Less: Reserve for obsolescence	0	0
Total	$972,526	$420,186

Statement_of_Accounts_Payable_

Statement of Accounts Payable and Accrued Expenses (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Accounts Payable and Accrued Liabilities [Line Items]	'	'
Accounts payable	$2,567,449	$2,866,017
Owed to officer	30,650	16,088
Accrued interest	453,827	1,016,584
Accrued rent expense	135,874	135,874
Accrued salaries, bonuses and payroll taxes	113,615	824,492
Accrued professional fees	250,434	230,433
Accounts payable and accrued expenses	$3,551,849	$5,089,488

Unsecured_Notes_Net_Debt_Disco

Unsecured Notes Net Debt Discount (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Unsecured Convertible Notes	$2,739,271	$1,450,333
Debt discount	-76,147	-70,063
Unsecured Debt	2,663,124	1,380,270
Less long term portion	259,479	103,912
Short term portion	$2,403,645	$1,276,358

SHORT_TERM_DEBT_NET_OF_DEBT_DI2

SHORT TERM DEBT, NET OF DEBT DISCOUNT - Additional Information (Detail) (USD $)	6 Months Ended
	Jun. 30, 2014	Jan. 31, 2014	Dec. 31, 2013
Short-term Debt [Line Items]	'	'	'
Conversion price of note	$0.20	'	'
Debt discount	$76,147	'	$70,063
Debt payable and Accrued interest	506,801	'	'
Gains (losses) on restructuring of debt	18,378	'	'
Troubled debt restructuring, debtor, current period, gain (loss) on restructuring, per share, net	$0	'	'
Maximum	'	'	'
Short-term Debt [Line Items]	'	'	'
Proceeds from sale of unsecured convertible notes percentage	15.00%	'	'
Minimum	'	'	'
Short-term Debt [Line Items]	'	'	'
Proceeds from sale of unsecured convertible notes percentage	12.00%	'	'
One Affiliated Investor	'	'	'
Short-term Debt [Line Items]	'	'	'
Debt outstanding	'	'	2,000,000
Notes Payable	'	2,000,000	'
Three Accredited Investors	'	'	'
Short-term Debt [Line Items]	'	'	'
Conversion price of note	'	$0.20	'
Debt outstanding	'	'	249,535
Notes Payable	'	249,535	'
Debt instrument fair value	'	223,548	'
Loss on debt modification expense	25,987	'	'
Loss on debt restructuring	$0	'	'
Common Stock	'	'	'
Short-term Debt [Line Items]	'	'	'
Convertible preferred stock, shares issued upon conversion	1,336,918	'	'
Convertible preferred stock value issued upon conversion	43,725	'	'
Series G Preferred Stock	'	'	'
Short-term Debt [Line Items]	'	'	'
Preferred stock, value, issued	'	232,500	'
Notes Payable	'	'	'
Short-term Debt [Line Items]	'	'	'
Debt outstanding	'	'	465,872
Convertible Note 15%	'	'	'
Short-term Debt [Line Items]	'	'	'
Proceeds from convertible debt	1,495,030	'	'
Issuance of common stock subscribed (in shares)	561,918	'	'
Debt discount	77,207	'	'
Convertible Note 15% | Accredited Investor	'	'	'
Short-term Debt [Line Items]	'	'	'
Proceeds from unsecured notes payable	$1,495,030	'	'

SHORT_TERM_DEBT_RELATED_PARTIE1

SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT - Additional Information (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014
			Convertible Notes Payable
Short Term Debt - Related Parties, Net Of Debt Discount [Line Items]	'	'	'
Proceeds from Unsecured Notes Payable	'	'	$1,085,030
Debt instrument, interest rate, stated percentage	'	'	12.00%
Debt outstanding	'	'	100,000
Issuance of common stock subscribed (in shares)	'	'	125,000
Debt discount	$76,147	$70,063	$26,740

Fair_Value_Hierarchy_For_Finan

Fair Value Hierarchy For Financial Assets Measured at Fair Value on Recurring Basis (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'
Derivative liability - Conversion Feature	$790,000	$318,000
Total liabilities	790,000	318,000
Level 1	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Derivative liability - Conversion Feature	0	0
Total liabilities	0	0
Level 2	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Derivative liability - Conversion Feature	0	0
Total liabilities	0	0
Level 3	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Derivative liability - Conversion Feature	790,000	318,000
Total liabilities	$790,000	$318,000

Summary_of_Changes_in_Fair_Val

Summary of Changes in Fair Value of Level Three Financial Liabilities (Detail) (Derivative Liabilities, USD $)	6 Months Ended
	Jun. 30, 2014
Derivative Liabilities	'
Derivative [Line Items]	'
Balance at December 31, 2013	$318,000
Derivative converted into Equity	-8,000
Change in fair market value of Conversion Feature	480,000
Balance at June 30, 2014	$790,000

Warrant_Activity_Detail

Warrant Activity (Detail) (USD $)	6 Months Ended
	Jun. 30, 2014
Class of Warrant or Right [Line Items]	'
Number of Warrants, Outstanding at December 31, 2013	19,323,406
Granted, Number of Warrants	0
Exercised, Number of Warrants	-531,262
Expired or cancelled, Number of Warrants	0
Number of Warrants, Outstanding and exercisable at June 30, 2014	18,792,144
Weighted Average Exercise Price, Outstanding at December 31, 2013	$0.20
Granted, Weighted Average Exercise Price	$0
Exercised, Weighted Average Exercise Price	$0.10
Expired or cancelled, Weighted Average Exercise Price	$0
Weighted Average Exercise Price, Outstanding and exercisable at June 30, 2014	$0.20
Remaining Contractual Term, Outstanding at December 31, 2013	'63 months
Granted, Remaining Contractual Term	'0 months
Exercised, Remaining Contractual Term	'0 months
Expired or cancelled, Remaining Contractual Term	'0 months
Aggregate Intrinsic Value, Outstanding at December 31, 2013	$300,000
Granted, Aggregate Intrinsic Value	0
Exercised, Aggregate Intrinsic Value	0
Expired or cancelled, Aggregate Intrinsic Value	0
Aggregate Intrinsic Value, Outstanding at June 30, 2014	$0
Maximum	'
Class of Warrant or Right [Line Items]	'
Remaining Contractual Term, Outstanding and exercisable at June 30, 2014	'88 months
Minimum	'
Class of Warrant or Right [Line Items]	'
Remaining Contractual Term, Outstanding and exercisable at June 30, 2014	'8 months

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) (USD $)	Jun. 30, 2014
Commitments and Contingencies [Line Items]	'
2014	$1,800,000
2015	2,100,000
2016	2,700,000
2017	3,200,000
2018	3,800,000
Future minimum royalty payments due	$1,350,000

SUBSEQUENT_EVENTS_Additional_I

SUBSEQUENT EVENTS - Additional Information (Detail) (USD $)	1 Months Ended		3 Months Ended	6 Months Ended
	Aug. 01, 2014	Sep. 30, 2013	Sep. 30, 2013	Jun. 30, 2014
		Warrant [Member]	12% Secured subordinated convertible promissory note [Member]	12% Secured subordinated convertible promissory note [Member]
Subsequent Event [Line Items]	'	'	'	'
Proceeds from Issuance of Commercial Paper	'	'	$1,000,000	'
Debt Instrument, Interest Rate, Effective Percentage	'	'	12.00%	'
Long-term Debt, Gross	'	'	1,500,000	'
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	'	2,500,000	'	'
Debt Instrument, Maturity Date	'	'	14-Jul-15	'
Description of Reduction on Principal Amount of Notes	'	'	'	'a registration statement with the Securities and Exchange Commission (the SEC) covering the resale of the shares of Common Stock issuable upon conversion of the Note and exercise of the Warrant on or before 45 days after July 14, 2014, the principal amount of the Note shall be reduced by $200,000, and if the registration statement is declared effective by the SEC within 120 days of July 14, 2014, the principal amount of the Notes shall be further reduced by $300,000.
Description on Conversion Price of Common Stock	'	'	'	'Principal and accrued but unpaid interest is convertible into shares of the Company’s Common Stock at a price (the “Conversion Price”) equal the lesser (i) $0.35 per share, or (ii) 62% of the lowest trading price of the Common Stock as quoted by Bloomberg L.P. for the ten trading days immediately preceding the date of conversion (subject to adjustments as provided in the Note). However, in no event shall the Conversion Price be less than $0.031 per share (the “Floor Price”).
Reducing the principal amount	$1,300,000	'	'	'